AI assistant
PageGroup PLC — Director's Dealing 2018
Jun 6, 2018
5296_dirs_2018-06-06_89f84af7-490b-453b-be79-5e7633357d6f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4994Q
PageGroup plc
06 June 2018
PageGroup plc (the "Company")
Notification of Interests of Directors
In accordance with Article 19 of the EU Market Abuse Regulation, notification is hereby given of transactions in the ordinary shares of the Company as follows:
On 5 June 2018, Steve Ingham sold 650,000 Ordinary shares of 1p each in the Company. Mr Ingham continues to hold 851,625 Ordinary shares.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Steve Ingham
2
Reason for the notification
a)
Position/status
Chief Executive Officer
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a)
Name
PageGroup plc
b)
LEI
213800JK5ZEQW4AB8G71
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
1p Ordinary shares each in PageGroup plc
ISIN: GB0030232317
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £5.46888 | 650,000 |
d)
Aggregated information
- Aggregated volume
- Price
650,000
£3,554,772
e)
Date of the transaction
2018-06-06
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
Elaine Marriner, Company Secretary Tel 01932 264148
6 June 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEANKKESAPEEF